![]() |
市場調查報告書
商品編碼
2128238
高強度聚焦超音波(HIFU)市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測High Intensity Focused Ultrasound Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
全球高強度聚焦超音波市場預計到2025年將達到12.5億美元,從2026年的13.4億美元成長到2034年的24.3億美元,預測期內複合年成長率(CAGR)為7.7%。北美地區引領全球市場,預計到2025年將佔據32.8%的市場佔有率,這主要得益於先進的醫療基礎設施、非侵入性療法的日益普及、法規核准的進展以及MRI引導和機器人輔助高強度聚焦超音波系統的日益廣泛應用。
高強度聚焦超音波是一種非侵入性治療技術,它利用聚焦聲能精確破壞目標組織,無需手術切口。由於其能夠縮短住院時間、減少康復時間並改善患者預後,該技術已在前列腺癌治療、神經系統疾病、子宮肌瘤、血管疾病和醫學美容等領域中廣泛應用。對非手術治療日益成長的需求以及持續的技術創新預計將在未來幾年推動市場擴張。
市場趨勢
影響高強度聚焦超音波(HIFU)市場的最重要趨勢之一是人工智慧(AI)、機器人技術、磁振造影(MRI)引導、即時影像和先進治療計劃軟體的整合。這些技術提高了治療精確度、工作流程效率、醫生信心和病人安全性。製造商正逐漸將HIFU定位為多專科治療平台,而非單一適應症的醫療設備。持續的產品創新,例如AI驅動的標靶定位和MRI相容系統,正在進一步加速HIFU在醫院和專科診所的普及應用。
市場促進因素
前列腺癌、神經系統疾病和泌尿系統疾病的日益增加仍然是市場成長的最強勁驅動力之一。患者和醫療專業人員越來越傾向於選擇非侵入性治療,以減少手術相關的併發症、出血、疼痛和恢復時間。根據美國癌症協會預測,到2025年,美國將新增約313,780例前列腺癌病例,將顯著增加對高強度聚焦超音波(HIFU)治療系統的需求。 HIFU在腫瘤學、神經病學和醫學美容領域的臨床應用範圍不斷擴大,也持續推動市場需求的成長。
市場限制因素
儘管市場前景可期,但高昂的設備成本仍是市場擴張的主要挑戰。高強度聚焦超音波(HIFU)系統需要先進的影像技術、機器人引導、專用耗材、訓練有素的醫生以及漫長的法規核准流程,因此需要大量的資本投入。此外,部分HIFU手術(尤其是針對新的臨床適應症)的保險報銷有限,也阻礙了對成本敏感的醫療機構和新興市場對該技術的採用。
市場機遇
將高強度聚焦超音波(HIFU)的應用拓展到前列腺癌以外的領域,例如神經系統疾病、女性健康、血管疾病、良性前列腺增生(BPH)、子宮內膜異位症和標靶藥物遞送,蘊藏著巨大的成長機會。隨著臨床研究的不斷深入和法規核准的日益完善,這項技術的治療潛力正在不斷擴大。近期評估HIFU治療子宮內膜異位症和靜脈曲張的臨床研究表明,未來幾年該技術將為生產者帶來商業性機會。
市場挑戰
熟練操作先進高強度聚焦超音波(HIFU)系統的醫療專業人員短缺,持續限制市場成長。成功的HIFU治療需要超音波物理學、影像技術、患者選擇、治療計畫制定、術後後續觀察等的專業知識。受過訓練的專業人員數量有限,尤其是在開發中國家,這可能會阻礙這項技術的廣泛應用,儘管市場需求不斷成長。
依產品類型分類,市場分為「設備」及「耗材及配件」兩大類。 2025年,「耗材及配件」細分市場將成為市場成長的主要驅動力,這主要得益於對藥筒、探針、治療頭、耦合劑、牙科手機和一次性治療組件的持續需求。 「設備」細分市場預計在預測期內將以6.4%的複合年成長率成長。
依應用領域分類,細分市場包括前列腺癌、子宮肌瘤、神經病變、美容整形等領域。在皮膚緊緻、除皺、拉皮和塑形等手術需求不斷成長的推動下,美容整形領域預計將在2025年佔據最大的市場佔有率。預計到2026年,該領域將佔市場佔有率的44.5%。同時,前列腺癌領域預計到2034年將以6.5%的複合年成長率成長。
按最終用戶分類,市場可分為醫院和門診手術中心 (ASC)、專科診所、物理治療和復健中心、影像中心以及其他機構。預計到 2025 年,專科診所主導市場,這主要得益於門診高強度聚焦超音波 (HIFU) 手術量的增加以及患者對微創美容和泌尿系統治療日益成長的偏好。預計到 2026 年,專科診所將佔市場佔有率的 43.5%,而醫院和門診手術中心預計將以 7.1% 的複合年成長率成長。
北美仍然是最大的區域市場,預計到 2025 年將達到 4.1 億美元。在 FDA 的有利批准以及非切口神經外科和腫瘤外科手術日益普及的支持下,美國市場預計到 2026 年將達到 3.9 億美元,約佔全球銷售額的 29.4%。
由於其先進的醫療基礎設施以及高強度聚焦超音波(HIFU)在治療前列腺癌、皮膚病和神經科方面的日益廣泛的應用,預計到2026年,歐洲市場規模將達到3.4億美元,複合年成長率為6.8%。其中,德國市場預計將達到8,000萬美元,英國市場預計將達到6,000萬美元。
預計2026年,亞太地區市場規模將達3.8億美元,成為全球第二大區域市場。其中,中國預計將達到1.9億美元,日本9000萬美元,印度3000萬美元,這主要得益於醫療基礎設施的不斷完善、患者數量的增加以及先進非侵入性治療技術的普及。
在拉丁美洲、中東和非洲,由於醫療領域投資增加以及人們對高強度聚焦超音波(HIFU)技術的認知度提高,預計市場將實現溫和成長。拉丁美洲市場預計到2026年將達到1.2億美元,海灣合作理事會(GCC)市場預計約3,000萬美元。
The global high intensity focused ultrasound (HIFU) market was valued at USD 1.25 billion in 2025 and is projected to grow from USD 1.34 billion in 2026 to USD 2.43 billion by 2034, registering a CAGR of 7.7% during the forecast period. North America dominated the global market with a 32.8% market share in 2025, driven by advanced healthcare infrastructure, growing adoption of non-invasive treatments, favorable regulatory approvals, and increasing installation of MRI-guided and robotic HIFU systems.
High intensity focused ultrasound is a non-invasive therapeutic technology that uses focused acoustic energy to precisely destroy targeted tissues without requiring surgical incisions. The technology has gained widespread acceptance across prostate cancer treatment, neurological disorders, uterine fibroids, vascular diseases, and medical aesthetics due to its ability to minimize hospital stays, reduce recovery time, and improve patient outcomes. Growing demand for incision-free therapies and continuous technological innovation are expected to drive market expansion over the coming years.
Market Trends
One of the most significant trends shaping the HIFU market is the integration of artificial intelligence (AI), robotics, MRI guidance, real-time imaging, and advanced treatment planning software. These technologies improve treatment precision, workflow efficiency, physician confidence, and patient safety. Manufacturers are increasingly positioning HIFU as a multi-specialty treatment platform rather than a single-indication device. Continuous product innovation, including AI-assisted targeting and MRI-compatible systems, is further accelerating adoption across hospitals and specialty clinics.
Market Drivers
The increasing prevalence of prostate cancer, neurological disorders, and urological diseases remains one of the strongest drivers of market growth. Patients and healthcare providers are increasingly choosing non-invasive treatment options that reduce surgical complications, bleeding, pain, and recovery periods. According to the American Cancer Society, approximately 313,780 new prostate cancer cases were expected in the U.S. during 2025, significantly increasing demand for HIFU treatment systems. Expanding clinical applications in oncology, neurology, and medical aesthetics continue to strengthen market demand.
Market Restraints
Despite promising growth, high equipment costs remain a major challenge for market expansion. HIFU systems require advanced imaging technologies, robotic guidance, specialized consumables, highly trained physicians, and lengthy regulatory approval processes, resulting in substantial capital investment. Limited reimbursement for several HIFU procedures, particularly newer clinical indications, also discourages adoption in cost-sensitive healthcare facilities and emerging markets.
Market Opportunities
Expanding HIFU applications beyond prostate cancer into neurology, women's health, vascular disorders, benign prostatic hyperplasia (BPH), endometriosis, and targeted drug delivery presents substantial growth opportunities. Increasing clinical research and regulatory approvals are broadening the technology's therapeutic potential. Recent clinical studies evaluating HIFU for endometriosis and varicose vein treatment demonstrate the expanding commercial opportunities available to manufacturers in the coming years.
Market Challenges
A shortage of skilled healthcare professionals capable of operating sophisticated HIFU systems continues to limit market growth. Successful HIFU procedures require expertise in ultrasound physics, imaging interpretation, patient selection, treatment planning, and post-treatment monitoring. Limited availability of trained specialists, particularly in developing countries, may slow technology adoption despite increasing demand.
Based on product type, the market is divided into instruments and consumables & accessories. The consumables & accessories segment dominated the market in 2025, supported by recurring demand for cartridges, probes, treatment tips, coupling media, handpieces, and disposable procedure components. The instruments segment is expected to grow at a CAGR of 6.4% during the forecast period.
By application, the market includes prostate cancer, uterine fibroids, neurological disorders, aesthetics & cosmetology, and others. The aesthetics & cosmetology segment accounted for the largest market share in 2025 due to increasing demand for skin tightening, wrinkle reduction, facial lifting, and body contouring procedures. The segment is projected to account for 44.5% of the market in 2026. Meanwhile, the prostate cancer segment is anticipated to expand at a CAGR of 6.5% through 2034.
Based on end user, the market is segmented into hospitals & ambulatory surgical centers (ASCs), specialty clinics, physiotherapy & rehabilitation centers, diagnostic imaging centers, and others. Specialty clinics dominated the market in 2025 due to increasing outpatient HIFU procedures and growing patient preference for minimally invasive aesthetic and urological treatments. The segment is expected to account for 43.5% of the market in 2026, while hospitals & ASCs are projected to grow at a CAGR of 7.1%.
North America remained the largest regional market, reaching USD 0.41 billion in 2025. The U.S. market is expected to reach USD 0.39 billion in 2026, accounting for approximately 29.4% of global revenue, supported by favorable FDA approvals and increasing adoption of incision-free neurological and oncology procedures.
Europe is projected to reach USD 0.34 billion in 2026, growing at a CAGR of 6.8%, driven by advanced healthcare infrastructure and expanding use of HIFU for prostate cancer, dermatology, and neurological treatments. Germany is expected to generate USD 0.08 billion, while the U.K. market is projected at USD 0.06 billion.
Asia Pacific is forecast to reach USD 0.38 billion in 2026, becoming the second-largest regional market. China is expected to generate USD 0.19 billion, Japan USD 0.09 billion, and India USD 0.03 billion, supported by expanding healthcare infrastructure, rising patient populations, and growing adoption of advanced non-invasive therapies.
Latin America and the Middle East & Africa are expected to experience moderate growth due to increasing healthcare investments and rising awareness of HIFU technologies. The Latin America market is projected to reach USD 0.12 billion in 2026, while the GCC market is expected to generate approximately USD 0.03 billion.
Competitive Landscape
The HIFU market remains competitive, with leading companies focusing on regulatory approvals, product innovation, strategic collaborations, and global expansion. Major participants include Insightec, EDAP TMS, Sonablate Corp, Profound Medical, Chongqing Haifu Technology Co., Ltd., Theraclion, ALPINION Medical Systems, CLASSYS Inc., HIRONIC Co., Ltd., and EUNSUNG GLOBAL. Recent developments include Theraclion's EU MDR certification for SONOVEIN, Profound Medical's partnership with Siemens Healthineers, Insightec's FDA approval for Exablate Prime, and Merz Aesthetics' launch of Ultherapy PRIME, highlighting continuous technological advancement within the market.
Conclusion
The high intensity focused ultrasound market is poised for sustained growth as healthcare providers increasingly adopt non-invasive treatment technologies that improve patient outcomes while reducing recovery time and surgical risks. Rising incidence of prostate cancer, neurological disorders, and aesthetic procedures, combined with advances in AI, robotic guidance, and MRI-compatible systems, will continue to drive market expansion. Although high equipment costs, reimbursement limitations, and shortages of trained professionals remain challenges, expanding clinical indications and continuous technological innovation are expected to create significant growth opportunities. With the market projected to grow from USD 1.25 billion in 2025 to USD 2.43 billion by 2034, HIFU technology is expected to play an increasingly important role in modern minimally invasive healthcare.
Segmentation By Product Type, Application, End-user, and Region
By Product Type * Instruments
By Application * Prostate Cancer
By End-user * Hospitals & ASCs
By Region * North America (By Product Type, Application, End-user, and Country)